Press releases
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Apr 1, 2008
Results from TAXUS IV and V randomized clinical trials favor DES compared to bare-metal stents
-
Mar 31, 2008
At two years, Company's TAXUS® and PROMUS™ Stents demonstrate positive and similar outcomes
-
Mar 31, 2008
Sale is the latest example of Company's commitment to realigning its cost structure; overall goal is to strengthen Boston Scientific for the future
-
Mar 29, 2008
Two-year outcomes confirm the favorable results seen in previous clinical trials
-
Mar 29, 2008
One-year pooled ARRIVE data showed similarly low rates of stent-related cardiac death, myocardial infarction, stent thrombosis, and major cardiac events across the two patient subsets
-
Mar 25, 2008
Presentations to include clinical data for the TAXUS® paclitaxel-eluting coronary stent in a variety of high-risk patient populations
-
Mar 11, 2008
A live webcast and replay of the March 18 session will be available. Learn how to tune in
-
Mar 3, 2008
ACUITY® Spiral lead offers flexibility for placement in small, medium and large veins
-
Feb 28, 2008
Forty implants of COGNIS™ cardiac resynchronization therapy defibrillator (CRT-D) and TELIGEN™ implantable cardioverter defibrillator (ICD) performed in 14 hospitals in six countries
-
Feb 26, 2008
Jay J. Schnitzer, M.D., Ph.D. to join Company's Clinical Sciences organization effective March 24